CBD Global Sciences Initiates CBD Distillate Supplier Relationship with Harmony Hemp

Tickers: XCNQ:CBDN
Tags: #MedicinalMarijuana, #Mining, #Cannabis, #Healthcare

Denver, Colorado – TheNewswire – January 7, 2020 – CBD Global Sciences, Inc. (CSE:CBDN) (CNSX:CBDN.CN) (Frankfurt:GS3), “CBD Global” or the “Company”), is pleased to announce a significant initial purchase order and final delivery of CBD Distillate to Harmony Hemp a major manufacturer and seller of high-quality CBD products sold as both proprietary branded and private-label throughout the United States.

Harmony Hemp (https://harmonyhemp.com/) intends to purchase additional distillate over the coming months as they continue to see growing demand and continued expansion into additional national retail chains. CBD Global and Harmony Hemp are anticipating their new relationship will expand into a more formal definitive supply agreement.

Brad Wyatt, CEO of CBD Global, stated, “CBD Global is pleased to be a supplier to Harmony Hemp of our high-quality distillate product grown on our own Colorado farms through our wholly owned subsidiary Strasburg Pharms”. Wyatt added, “As a seed-to-sale fully vertically integrated operator, we are focused on providing the highest quality raw materials for our own products as well as those of our carefully selected partners. We look forward to our expanding relationship with Harmony Hemp as they continue the rapid growth of their diversified product line into their many retail channels”.

Courtney Roundy, CEO of Harmony Hemp, explained, “We have been working closely with CBD Global Sciences for several months and we believe that their commitment to stringent internal quality controls match well with our own commitment to providing the highest quality products available in the market to the end consumer”. Roundy added, “We are excited to move our relationship forward with CBD Global Sciences”.

ABOUT CBD GLOBAL SCIENCES INC.

CBD Global Sciences, Inc., is a vertically integrated hemp-based CBD producer, extractor, and branding investment vehicle which currently owns two product categories, branded under the name AETHICS (www.aethics.com) and CANNAOIL (www.cannaoilshop.com), which include CBD Oil tinctures (liquid products), CBD capsules, CBD topicals and CBD hydration products. CBD Global Sciences hemp-derived CBD extracts are sold through select distributors, brick and mortar retailers, and online.

CBD Global Sciences, through its wholly owned subsidiary, Strasburg Pharms, grows and operates irrigated land in Colorado, that grows hemp with only all-natural Colorado water, soil, sun and nutrients and NEVER sprayed with pesticides or chemicals. Our genetics are hand selected and maintained to present the best cannabinoid profile with extremely high CBD. The extraction/processing facility, operated by CBD Global Sciences, is located approximately 40 minutes from the farm.

For further information, please contact Bruce Nurse, Investor Relations, (888) 401-2239, [email protected]

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAS REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to future developments and the business and operations of the Corporation after the CSE listing. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to general business, economic, competitive, political and social uncertainties; and delay or failure to receive board, shareholder or regulatory approvals. Readers should not place undue reliance on forward-looking statements. The Corporation disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

NOT FOR DISTRIBUTION OR DISSEMINATION INTO THE UNITED STATES

Copyright (c) 2020 TheNewswire – All rights reserved.